Portal de Periódicos da CAPES

Inhibition of Platelet Aggregation by Putrescine, Spermidine, and Spermine in Hypercholesterolemic Rabbits

2000; Elsevier BV; Volume: 31; Issue: 6 Linguagem: Inglês

10.1016/s0188-4409(00)00238-1

1873-5487

Norma Corona de la Peña, Jorge A. Sosa‐Melgarejo, Rubén Román Ramos, José D. Méndez,

Cannabis and Cannabinoid Research

Hypercholesterolemia causes alterations in platelet function. Platelet hyperaggregation is considered a predisposing factor for atherosclerosis. In this paper, the antiaggregating effect of the polyamines putrescine, spermidine, and spermine was studied on platelets of normal and hypercholesterolemic rabbits. New Zealand rabbits were fed with a cholesterol-enriched diet for 10 weeks. Lipids and glucose were determined in serum. The assays of platelet aggregation were carried out using platelet-rich plasma (PRP) obtained from both control and cholesterol-fed rabbits. We used 2.5 μmol /mL ADP and 2 μg/mL collagen as inductors of platelet aggregation. In addition, arginase activity and L-arginine content were determined in PRP. Serum total cholesterol and LDL-cholesterol concentrations were increased from 26.3 ± 8.1 to 1,485.0 ± 26.8 mg/dL and from 15.9 ± 5.9 to 1,383.8 ± 58.9 mg/dL, respectively, whereas triglyceride concentration increased from 88.3 ± 35.6 to 411.0 ± 154.5 mg/dL upon cholesterol feeding. Seventy-five percent of platelet aggregation inhibition was observed with 10 μM of polyamines in PRP of normal rabbits. Spermine inhibited platelet aggregation by 54% in PRP of hypercholesterolemic rabbits when ADP was used as agonist. The order of polyamine action was spermine > spermidine > putrescine. In addition, we found that platelet arginase activity and L-arginine content were unaltered upon hypercholesterolemia. These results show that the polyamines putrescine, spermidine, and spermine have antagonist action in platelet aggregation and suggest a key role of polyamines in platelet aggregation under normal and hypercholesterolemic conditions.